|
Hamada, Katsuyuki; Sakaue, Morito; Sarkar, Asis et al. (2005) Immune responses to repetitive adenovirus-mediated gene transfer and restoration of gene expression by cyclophosphamide or etoposide. Gynecol Oncol 99:S177-86
|
|
Hamada, Katsuyuki; Ueda, Norifumi; Ito, Masaharu et al. (2005) The nude rat as an orthotopic model for cervical cancer. Gynecol Oncol 99:S159-65
|
|
Yen, N; Ioannides, C G; Xu, K et al. (2000) Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53). Cancer Gene Ther 7:530-6
|
|
Fukazawa, T; Fujiwara, T; Morimoto, Y et al. (1999) Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells. Oncogene 18:2189-99
|
|
Swisher, S G; Roth, J A; Nemunaitis, J et al. (1999) Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J Natl Cancer Inst 91:763-71
|
|
Roth, J A; Swisher, S G; Meyn, R E (1999) p53 tumor suppressor gene therapy for cancer. Oncology (Williston Park) 13:148-54
|
|
Nishizaki, M; Fujiwara, T; Tanida, T et al. (1999) Recombinant adenovirus expressing wild-type p53 is antiangiogenic: a proposed mechanism for bystander effect. Clin Cancer Res 5:1015-23
|
|
Roth, J A; Swisher, S G; Merritt, J A et al. (1998) Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement. Semin Oncol 25:33-7
|
|
Mukhopadhyay, T; Multani, A S; Roth, J A et al. (1998) Reduced telomeric signals and increased telomeric associations in human lung cancer cell lines undergoing p53-mediated apoptosis. Oncogene 17:901-6
|
|
Cristiano, R J; Xu, B; Nguyen, D et al. (1998) Viral and nonviral gene delivery vectors for cancer gene therapy. Cancer Detect Prev 22:445-54
|
Showing the most recent 10 out of 77 publications
